Selegiline Patch for Treatment of Nicotine Dependence

NCT01330030 Phase 2 COMPLETED Results posted

Relapse to smoking is a common problem affecting smokers who seek treatment. The purpose of this study is examine whether selegiline, given in the form of a skin patch, is effective in stopping smoking.

Details

Lead sponsor	Stanford University
Phase	Phase 2
Status	COMPLETED
Enrolment	243
Start date	2005-07
Completion	2011-07

Conditions

• Tobacco Use Disorder

Interventions

• Selegiline
• matching placebo

Primary outcomes

• Expired-air Carbon Monoxide Confirmed Smoking Abstinence — 52 weeks
  expired-air carbon monoxide confirmed smoking abstinence at 52 weeks

Countries

United States